etoposide has been researched along with Adult-Onset Still Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, CD; Chen, S; Fu, Q; Li, T; Lv, L; Wang, R; Wang, X; Ye, S | 1 |
| Maeda, S; Naniwa, T; Ohmura, SI; Tamechika, S; Uehara, K; Yamabe, T | 1 |
| Cheng, FW; Lin, A; Ma, TP; Ng, PC | 1 |
| Jin, J | 1 |
| Kanemoto, M; Karahashi, T; Kato, T; Kobayashi, C; Morita, S; Tanabe, J | 1 |
5 other study(ies) available for etoposide and Adult-Onset Still Disease
| Article | Year |
|---|---|
Short-term, low-dose etoposide in refractory adult-onset Still's disease-associated macrophage activation syndrome.
Topics: Adult; Etoposide; Humans; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation Syndrome; Prognosis; Still's Disease, Adult-Onset | 2022 |
Successful use of short-term add-on tocilizumab for refractory adult-onset still's disease with macrophage activation syndrome despite treatment with high-dose glucocorticoids, cyclosporine, and etoposide.
Topics: Antibodies, Monoclonal, Humanized; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Etoposide; Glucocorticoids; Humans; Immunosuppressive Agents; Macrophage Activation Syndrome; Molecular Targeted Therapy; Severity of Illness Index; Still's Disease, Adult-Onset; Treatment Outcome | 2020 |
Neonatal Haemophagocytic Lymphohistiocytosis Associated with Maternal Adult-Onset Still's Disease.
Topics: Cyclosporine; Etoposide; Female; Fever; Genetic Testing; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Lymphohistiocytosis, Hemophagocytic; Pregnancy; Pregnancy Complications; Prenatal Diagnosis; Still's Disease, Adult-Onset | 2016 |
A continuous infusion of etoposide and doxorubicin for refractory MAS management.
Topics: Doxorubicin; Etoposide; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Infusions, Intravenous; Macrophage Activation Syndrome; Methylprednisolone; Still's Disease, Adult-Onset; Topoisomerase II Inhibitors; Young Adult | 2016 |
A case of extranodal NK/T-cell lymphoma, nasal type mimicking typical manifestations of adult-onset Still's disease (AOSD) with hemophagocytic syndrome: diagnostic consideration between malignant lymphoma without lymphadenopathy and AOSD.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Dexamethasone; Diagnosis, Differential; Disease Progression; Etoposide; Herpesvirus 4, Human; Humans; Ifosfamide; Lymph Nodes; Lymphatic Diseases; Lymphoma, Extranodal NK-T-Cell; Male; Radiography; Splenomegaly; Still's Disease, Adult-Onset; Treatment Outcome | 2009 |